MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with C

Clobazam

Clobazam 2.5mg capsules

No stability information

Stability notes for Clobazam 2.5mg capsules

There are no stability notes for this medicine.

Supplier

Clobazam 2.5mg capsules (Special Order)

Clobazam 10mg tablets

Compatible

Stability notes for Clobazam 10mg tablets

No stability data in MCAs available but no theoretical concerns with product.
Anecdotal reports of use in MCAs for up to 4 weeks (low quality evidence).

Provenance

This recommendation is based on the products Frisium 10mg tablets (Atnahs Pharma UK Ltd) and Clobazam 10mg tablets (Brown & Burk UK Ltd).

Suppliers (10) of Clobazam 10mg tablets
Clobazam 10mg tablets (A A H Pharmaceuticals Ltd)
Clobazam 10mg tablets (Accord-UK Ltd)
Clobazam 10mg tablets (Alliance Healthcare (Distribution) Ltd)
Clobazam 10mg tablets (Brown & Burk UK Ltd)
Clobazam 10mg tablets (Celix Pharma Ltd)
Clobazam 10mg tablets (Medihealth (Northern) Ltd)
Clobazam 10mg tablets (Phoenix Healthcare Distribution Ltd)
Clobazam 10mg tablets (Sigma Pharmaceuticals Plc)
Frisium 10mg tablets (Atnahs Pharma UK Ltd)
Frisium 10mg tablets (Sigma Pharmaceuticals Plc)

Clobazam 20mg tablets

Compatible

Stability notes for Clobazam 20mg tablets

No stability data in MCAs available but no theoretical concerns with product.
Anecdotal reports of use in MCAs for up to 4 weeks (low quality evidence).

Provenance

This recommendation is based on the products Frisium 10mg tablets (Atnahs Pharma UK Ltd) and Clobazam 20mg tablets (Brown & Burk UK Ltd).

Supplier

Clobazam 20mg tablets (Brown & Burk UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.